Minatuss (Butamirate Citrate)

Butamirate citrate, the active ingredient in Minatuss, is an antitussive presented as an oral dosage form for oral use. It suppresses dry, non‑productive coughs in adults and adolescents and acts centrally to reduce the cough reflex without affecting mucus clearance.

GNH USA supplies Minatuss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Butamirate citrate is an antitussive that reduces the frequency of dry, non‑productive coughs.

- Dry cough: provides symptomatic relief by decreasing cough frequency. - Non‑productive cough: alleviates throat irritation without affecting mucus clearance. - Cough associated with upper respiratory tract infections: helps control coughing episodes while the underlying infection resolves.

Butamirate citrate may cause adverse reactions, which are generally mild but can be serious in rare cases.

Common Side Effects: - Nausea: mild stomach upset reported by some patients. - Dizziness: transient light‑headedness, especially after the first dose. - Drowsiness: occasional sleepiness, advise caution when driving. - Headache: mild to moderate headache in a minority of users. - Dry mouth: reduced salivation leading to throat discomfort.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or angioedema requiring medical attention. - Severe dizziness or vertigo: may indicate central nervous system involvement. - Hallucinations or confusion: rare neuropsychiatric events. - Respiratory depression: extremely rare but serious, especially if combined with other depressants.

When prescribing or dispensing butamirate citrate, consider the following precautions.

- Assess hypersensitivity: avoid use in patients with known allergy to butamirate citrate. - Hepatic impairment: use with caution and monitor liver function. - Concomitant CNS depressants: avoid or adjust dose if combined with other sedatives. - Excessive sedation: monitor patients for profound drowsiness or impaired coordination. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Butamirate citrate can interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Other centrally acting cough suppressants: may lead to excessive suppression of the cough reflex. - Monoamine oxidase inhibitors (MAOIs): risk of heightened central nervous system effects.

Moderate Interactions (Monitor Closely): - Alcohol: can increase drowsiness and dizziness. - Sedating antihistamines: may enhance sedation. - Opioid analgesics: additive central depressant effects. - Benzodiazepines: potential for increased sedation and respiratory depression.